相关实验视频

Updated: Sep 16, 2025

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

SPARC:一个正交的Cas12a/Cas13a双通道CRISPR平台,可用于可靠的SNV识别和突变确认

Jialing Zhong^1,2, Yong Chen^1,3, Yueyu Dong^1,2

¹Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, 518060 Guangdong, P. R. China.

Analytical chemistry

|July 7, 2025

概括

我们开发了SPARC,这是一种新型的CRISPR试验,用于高度可靠的单核酸变体 (SNV) 检测. 这种双通道系统提高了用于精密医学和病原体识别的诊断准确度.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
遗传学遗传学是一个

背景情况:

基于CRISPR的核酸检测对于诊断至关重要,但面临信号模两可和特异性的挑战.
现有的方法往往难以区分真正的单核酸变体 (SNV) 与缺席的标,使解释复杂化.

研究的目的:

引入SPARC (用Cas12a/Cas13a进行特定和精确的突变识别),一种直角双通道CRISPR试验,以提高SNV检测可靠性.
解决当前CRISPR平台在临床诊断的特异性和信号解释方面的局限性.

主要方法:

SPARC集成了AsCas12a用于保存区域检测 (内部参考) 和DNA激活的LbuCas13a用于高特异性的SNV检测.
该试验使用复合酶聚合酶放大 (RPA) 和T7外核酶消化.
正角形设计区分SNV和没有目标,提高了诊断的清晰度.

主要成果:

斯帕克实现了超高灵敏度,检测核酸的度低至1 aM.
该平台通过准确检测乙型肝炎病毒 (HBV) 和其YMDD抗性突变,证明了强大的临床适用性.
SPARC成功地区分了真正的SNV和没有目标序列之间的差异.

结论:

SPARC提供了一种基于CRISPR的创新和多功能解决方案,用于可靠的SNV检测.
该平台显著提高了诊断准确性,为推进临床诊断和个性化医疗提供了巨大的潜力.
在基于CRISPR的检测中,SPARC克服了常见的模两可,提高了基因突变查和病原体识别的可靠性.

更多相关视频

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...